| abstract |
The invention relates to compounds of formula (I), or a salt thereof, wherein R1, G, L1L2, L3, and Y are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are inhibitors of one, or both of, ανβ1 integrin and ανβ6 integrin that are useful for treating fibrosis such as in nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IFF) and nonspecific interstitial pneumonia (NSTP). |